The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy
Abstract
This multicenter, randomized, double‐blind, crossover trial compared a 6 week course of oral prednisolone tapering from 60 mg to 10 mg daily with intravenous immunoglobulin (IVIg) 2.0 g/kg given over 1 to 2 days for treating chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Twenty‐four of the thirty‐two randomized patients completed both treatment periods. Both treatments produced significant improvements in the primary outcome measure, change in an 11‐point disability scale 2 weeks after randomization. There was slightly, but not significantly, more improvement after IVIg than with prednisolone, the mean difference between the groups in change in disability grade being 0.16 (95% CI = –0.35 to 0.66). There were also slightly, but not significantly, greater improvements favoring IVIg in the secondary outcome measures: time to walk 10 meters after 2 weeks and improvement in disability grade after 6 weeks. Results may have been biased against IVIg by the 8 patients who did not complete the second arm of the trial. A serious adverse event (psychosis) attributable to treatment occurred in 1 patient while on prednisolone and in none with IVIg.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kleyweg, R. P., Van Der Meché, F. G. A., & Schmitz, P. I. M. (1991) · Muscle & Nerve · doi:10.1002/mus.880141111 · Cited by 926
Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)
Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force (1991) · Neurology · doi:10.1212/wnl.41.5.617 · Cited by 856
Chronic Inflammatory Polyradiculoneuropathy
Millichap, J. G. (1997) · Pediatric Neurology Briefs · doi:10.15844/pedneurbriefs-11-12-6 · Cited by 822
Cross-Over Trials in Clinical Research
(1994) · Technometrics · doi:10.1080/00401706.1994.10485798 · Cited by 763
Meyler's Side Effects of Drugs
(2016) · Elsevier eBooks · doi:10.1016/c2009-1-62477-1 · Cited by 756
Interobserver agreement for the assessment of handicap in stroke patients.
Bamford, J. M., Sandercock, P. A., Warlow, C. P., & Slattery, J. (1989) · Stroke · doi:10.1161/01.str.20.6.828 · Cited by 693
Meyler's Side Effects of Drugs
Breckenridge, A. M. (1976) · BMJ · doi:10.1136/bmj.2.6030.307 · Cited by 691
Barohn, R. J. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520440064022 · Cited by 567
Plasma Exchange in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Dyck, P. J., Daube, J., O'Brien, P., Pineda, A., Low, P. A., Windebank, A. J., & Swanson, C. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140801 · Cited by 489
Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment
Dyck, P. J., O'Brien, P. C., Oviatt, K. F., Dinapoli, R. P., Daube, J. R., Bartleson, J. D., Mokri, B., Swift, T., Low, P. A., & Windebank, A. J. (1982) · Annals of Neurology · doi:10.1002/ana.410110205 · Cited by 483
Dyck, P. J., Litchy, W. J., Kratz, K. M., Suarez, G. A., Low, P. A., Pineda, A. A., Windebank, A. J., Karnes, J. L., & O'Brien, P. C. (1994) · Annals of Neurology · doi:10.1002/ana.410360607 · Cited by 471
MCOMBE, P. A., POLLARD, J. D., & MCLEOD, J. G. (1987) · Brain · doi:10.1093/brain/110.6.1617 · Cited by 458
Hahn, A. F., Bolton, C. F., Zochodne, D., & Feasby, T. E. (1996) · Brain · doi:10.1093/brain/119.4.1067 · Cited by 439
Hahn, A. F., Bolton, C. F., Pillay, N., Chalk, C., Benstead, T. J., Bril, V., Shumak, K. H., Vandervoort, M. K., & Feasby, T. E. (1996) · Brain · doi:10.1093/brain/119.4.1055 · Cited by 409
Goodkin, D. E., Hertsgaard, D., & Seminary, J. (1988) · PubMed · Cited by 314
Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England
Lunn, M. P. T., Manji, H., Choudhary, P. P., Hughes, R. A. C., & Thomas, P. K. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.5.677 · Cited by 276
Self-citationDoorn, P. A. V., Brand, A., Strengers, P. F. W., Meulstee, J., & Vermeulen, M. (1990) · Neurology · doi:10.1212/wnl.40.2.209 · Cited by 274
Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica
Gabriel, S. E., Sunku, J., Salvarani, C., O'Fallon, W. M., & Hunder, G. G. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780401022 · Cited by 239
Combined azathioprine and prednisone in chronic inflammatory‐demyelinating polyneuropathy
Dyck, P. J., O'Brien, P., Swanson, C., Low, P., & Daube, J. (1985) · Neurology · doi:10.1212/wnl.35.8.1173 · Cited by 227
Vermeulen, M., van Doorn, P. A., Brand, A., Strengers, P. F., Jennekens, F. G., & Busch, H. F. (1993) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.1.36 · Cited by 223
Self-citationPsychometric evaluation of a new sensory scale in immune-mediated polyneuropathies
Merkies, I. S. J., Schmitz, P. I. M., van der Meché, F. G. A., & van Doorn, P. A. (2000) · Neurology · doi:10.1212/wnl.54.4.943 · Cited by 215
Self-citationRandomized trial of interferon β-1a in chronic inflammatory demyelinating polyradiculoneuropathy
Hadden, R. D. M., Sharrack, B., Bensa, S., Soudain, S., & Hughes, R. A. (1999) · Neurology · doi:10.1212/wnl.53.1.57 · Cited by 156
Self-citationPulse cyclophosphamide therapy in chronic inflammatory demyelinating polyneuropathy
Good, J. L., Chehrenama, M., Mayer, R. F., & Koski, C. L. (1998) · Neurology · doi:10.1212/wnl.51.6.1735 · Cited by 142
Treatment of chronic inflammatory demyelinating polyneuropathy with cyclosporin-A.
Mahattanakul, W., Crawford, T. O., Griffin, J. W., Goldstein, J. M., & Cornblath, D. R. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.60.2.185 · Cited by 81
Cyclosporin A in the treatment of chronic demyelinating polyradiculoneuropathy.
Hodgkinson, S. J., Pollard, J. D., & McLeod, J. G. (1990) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.53.4.327 · Cited by 77
Cross-Over Trials in Clinical Research.
Green, J. R., & Senn, S. (1993) · Journal of the Royal Statistical Society Series A (Statistics in Society) · doi:10.2307/2983088 · Cited by 73
Evaluation of scales and measurement instruments in immune-mediated polyneuropathies
Merkies, I. S. J. (2001) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 17
Cited by
Hughes, R. A., Donofrio, P., Bril, V., Dalakas, M. C., Deng, C., Hanna, K., Hartung, H.-P., Latov, N., Merkies, I. S., & van Doorn, P. A. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70329-0 · Cited by 674
Self-citationUpdate on the use of immunoglobulin in human disease: A review of evidence
Perez, E. E., Orange, J. S., Bonilla, F., Chinen, J., Chinn, I. K., Dorsey, M., El-Gamal, Y., Harville, T. O., Hossny, E., Mazer, B., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.09.023 · Cited by 666
Joint Task Force of the EFNS and the PNS (2010) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2010.00245.x · Cited by 539
Chronic Inflammatory Demyelinating Polyneuropathy
Köller, H., Kieseier, B. C., Jander, S., & Hartung, H.-P. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041347 · Cited by 511
Clinical uses of intravenous immunoglobulin
Jolles, S., Sewell, W. A. C., & Misbah, S. A. (2005) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02834.x · Cited by 374
Metadata
- Authors
- Hughes, R., Bensa, S., Willison, H., Van Den Bergh, P., Comi, G., Illa, I., Nobile‐Orazio, E., Van Doorn, P., Dalakas, M., Bojar, M., Swan, A., & Inflammatory Neuropathy Cause and Treatment (INCAT) Group
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2001-07-30
- Volume
- 50
- Issue
- 2
- Pages
- 195-201
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2040160619
- Cited by
- 628
- References
- 27
- FWCI
- 14.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.